MedTrace Logo

Early Mobilization Following Elective Spine Surgery: Trial of In-bed Cycling

NCT07506720 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2026-06-22

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if early mobilization using an in-bed cycling device can reduce the amount of time patients spend in bed after elective spine surgery in adults.

The main questions it aims to answer are:

Does in-bed cycling on the day after surgery reduce the amount of time patients spend in bed over the next 24 hours?

Does in-bed cycling reduce the length of hospital stay and improve participation during physiotherapy assessment?

Researchers will compare patients who receive an in-bed cycling session plus standard postoperative care to patients who receive standard postoperative care alone to see if early in-bed cycling improves mobility and recovery after spine surgery.

Participants will:

Be randomly assigned to either a standard care group or an in-bed cycling group

Wear a fitness tracker to measure activity levels and time spent in bed

Receive standard postoperative care

Complete a 30-minute in-bed cycling session on the day after surgery (intervention group only)

Be monitored for pain and vital signs during the study period

Undergo a physiotherapy assessment to evaluate mobility and participation

Conditions

  • Spine
  • Post Surgery Patients
  • Recovery Method

Interventions

OTHER

Standard Postoperative Care plus In-Bed Cycling

Participants in this arm receive usual postoperative care following elective spine surgery plus a single supervised 30-minute in-bed cycling session on postoperative day 1. Cycling is performed using a portable ergometer in active or active-assisted mode under continuous physiological monitoring.

Sponsors & Collaborators

  • Medtronic Spine LLC

    collaborator INDUSTRY

  • Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2028-08-31
Completion
2029-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07506720 on ClinicalTrials.gov